Marketing authorization application for lecanemab as treatment for early alzheimer’s disease accepted by european medicines agency

TOKYO and CAMBRIDGE, Mass., Jan. 26, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (N...

January 26, 2023, 11:30 pm

Amazon offers $5 monthly prescription drug plan

Amazon (AMZN) announced the launch of RxPass, which will provide unlimited access to a roster of generic medic...

January 24, 2023, 7:20 pm

Catalyst pharmaceuticals comments on fda’s announcement of its position on orphan drug exclusivity in light of the 11th circuit decision in catalyst pharmaceuticals, inc. v. becerra

Announced Earlier Today-Notice Received from ANDA Filer for FIRDAPSE® CORAL GABLES, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals...

January 23, 2023, 6:25 pm

Walgreens lifts restrictions on purchases of children's cold medicines

Walgreens Boots Alliance Inc. WBA, -1.25% said Monday that it removed restrictions on purchases of over-the-counter children's cold medications. The p...

January 17, 2023, 2:36 pm

Omega therapeutics to present trial-in-progress poster for phase 1/2 mychelangelo™ i study at the american society of clinical oncology gastrointestinal cancers symposium

CAMBRIDGE, Mass., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pion...

January 17, 2023, 7:00 am

Pfizer expands commitment to ‘an accord for a healthier world' to meet unmet medical needs in 45 lower-income countries

Pfizer Inc. PFE, +0.29% said Tuesday it has expanded its commitment to ‘An Accord for a Healthier World' to include all of the ...

January 17, 2023, 6:54 am

Ing on china: "big beat in december activity data ... revising our gdp forecast higher"

ING response to China's data releases today, in brief:

• China's retail sales data was much stronger than expected in December even though...

  January 17, 2023, 4:27 am

Walgreens removes purchase limits on children's fever-reducing medications

Walgreens announced on Monday that it lifted an online cap for purchasing children's fever-reducing medicines ...

January 16, 2023, 11:59 am

: drug companies plan to raise prices on vital medicines to fund r&d, but they already spend more on shareholder returns than research

Drug companies say they need to raise prices on cancer drugs and other treatments to fund research. But they already spend more on stock buybacks and ...

January 14, 2023, 6:40 pm

: drug companies plan to raise prices on vital medicines to fund r&d, but they already spend more on shareholder returns

Drug companies say they need to raise prices on cancer drugs and other treatments to fund research. But they already spend more on stock buybacks and ...

January 13, 2023, 4:12 pm

Strength seen in revolution medicines, inc. (rvmd): can its 15.9% jump turn into more strength?

Revolution Medicines, Inc. (RVMD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate ...

January 12, 2023, 4:31 am

Biogen's (biib) partner eisai files maa for lecanemab in europe

Biogen's (BIIB) partner Eisai files a marketing authorization application to the European medicines Age...

January 11, 2023, 11:17 am

Solid biosciences reports inducement grant to chief financial officer and treasurer

CHARLESTOWN, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic ...

January 9, 2023, 9:26 pm

Solid biosciences to present at the 41st annual j.p. morgan healthcare conference

CAMBRIDGE, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic ...

January 9, 2023, 8:00 am

Aveo oncology stockholders approve acquisition by lg chem

BOSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) — AVEO Oncology (“AVEO”) (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company c...

January 6, 2023, 12:35 am

Oxford cannabinoid technologies hails 'milestone' as it submits phase i trial application for lead programme

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) (OCTP) said it has submitted a Phase 1 trial application for its lead programme (...

January 5, 2023, 7:14 am

Swiss cpi down to 2.8% yoy, but core rose to 2.0% yoy

Swiss CPI dropped -0.2% mom in December, due to several factors including falling prices for fuels and heating oil, fruiting vegetables and medicines....

January 4, 2023, 7:58 am

Annexon to present at 41st annual j.p. morgan healthcare conference

BRISBANE, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of...

January 4, 2023, 6:30 am

Chinook therapeutics to present at 41st annual j.p. morgan healthcare conference

SEATTLE, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, developmen...

January 3, 2023, 4:00 pm

Eqrx to present at the 41st annual j.p. morgan healthcare conference

CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) — EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and expan...

January 3, 2023, 1:00 pm